| Literature DB >> 20082599 |
Katalin Jemnitz1, Krisztina Heredi-Szabo, Judit Janossy, Eniko Ioja, Laszlo Vereczkey, Peter Krajcsi.
Abstract
ABCC2/Abcc2 (MRP2/Mrp2) is expressed at major physiological barriers, such as the canalicular membrane of liver cells, kidney proximal tubule epithelial cells, enterocytes of the small and large intestine, and syncytiotrophoblast of the placenta. ABCC2/Abcc2 always localizes in the apical membranes. Although ABCC2/Abcc2 transports a variety of amphiphilic anions that belong to different classes of molecules, such as endogenous compounds (e.g., bilirubin-glucuronides), drugs, toxic chemicals, nutraceuticals, and their conjugates, it displays a preference for phase II conjugates. Phenotypically, the most obvious consequence of mutations in ABCC2 that lead to Dubin-Johnson syndrome is conjugate hyperbilirubinemia. ABCC2/Abcc2 harbors multiple binding sites and displays complex transport kinetics.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20082599 DOI: 10.3109/03602530903491741
Source DB: PubMed Journal: Drug Metab Rev ISSN: 0360-2532 Impact factor: 4.518